Synthetic high-density lipoprotein nanoparticles for the treatment of Niemann–Pick diseases
Open Access
- 11 November 2019
- journal article
- research article
- Published by Springer Nature in BMC Medicine
- Vol. 17 (1) , 1-18
Abstract
Background: Niemann–Pick disease type C is a fatal and progressive neurodegenerative disorder characterized by the accumulation of unesterified cholesterol in late endosomes and lysosomes. We sought to develop new therapeutics for this disorder by harnessing the body’s endogenous cholesterol scavenging particle, high-density lipoprotein (HDL).Methods: Here we design, optimize, and define the mechanism of action of synthetic HDL (sHDL) nanoparticles.Results: We demonstrate a dose-dependent rescue of cholesterol storage that is sensitive to sHDL lipid and peptide composition, enabling the identification of compounds with a range of therapeutic potency. Peripheral administration of sHDL toNpc1 I1061Thomozygous mice mobilizes cholesterol, reduces serum bilirubin, reduces liver macrophage size, and corrects body weight deficits. Additionally, a single intraventricular injection into adultNpc1 I1061Tbrains significantly reduces cholesterol storage in Purkinje neurons. Since endogenous HDL is also a carrier of sphingomyelin, we tested the same sHDL formulation in the sphingomyelin storage disease Niemann–Pick type A. Utilizing stimulated Raman scattering microscopy to detect endogenous unlabeled lipids, we show significant rescue of Niemann–Pick type A lipid storage.Conclusions: Together, our data establish that sHDL nanoparticles are a potential new therapeutic avenue for Niemann–Pick diseases.Keywords
Funding Information
- National Institutes of Health (NS063967, NS007222, GM007767, HL125242)
- Parseghian Medical Research Foundation
- American Foundation for Pharmaceutical Education (N.A.)
- Niemann-Pick Canada (N.A.)
- Hope for Marion (None)
- University of Michigan Protein Folding Diseases Initiative (None)
This publication has 65 references indexed in Scilit:
- Normalization of Cholesterol Homeostasis by 2-Hydroxypropyl-β-cyclodextrin in Neurons and Glia from Niemann-Pick C1 (NPC1)-deficient MiceJournal of Biological Chemistry, 2012
- 5A Apolipoprotein Mimetic Peptide Promotes Cholesterol Efflux and Reduces Atherosclerosis in MiceThe Journal of Pharmacology and Experimental Therapeutics, 2010
- Structure/Function Relationships of Apolipoprotein A-I Mimetic PeptidesCirculation Research, 2010
- Endocytosis of beta-cyclodextrins is responsible for cholesterol reduction in Niemann-Pick type C mutant cellsProceedings of the National Academy of Sciences, 2010
- Amiloride inhibits macropinocytosis by lowering submembranous pH and preventing Rac1 and Cdc42 signalingJournal of Cell Biology, 2010
- The National Niemann-Pick Type C1 Disease Database: correlation of lipid profiles, mutations, and biochemical phenotypesJournal of Lipid Research, 2010
- Conditional Niemann-Pick C mice demonstrate cell autonomous Purkinje cell neurodegenerationHuman Molecular Genetics, 2009
- Label-Free Biomedical Imaging with High Sensitivity by Stimulated Raman Scattering MicroscopyScience, 2008
- NPC2 facilitates bidirectional transfer of cholesterol between NPC1 and lipid bilayers, a step in cholesterol egress from lysosomesProceedings of the National Academy of Sciences, 2008
- Niemann-Pick Type C1 I1061T Mutant Encodes a Functional Protein That Is Selected for Endoplasmic Reticulum-associated Degradation Due to Protein MisfoldingJournal of Biological Chemistry, 2008